Cargando…

Type 2 Diabetes: Uses of thiazolidinediones and insulin

Detalles Bibliográficos
Autor principal:	T. Bloomgarden, Zachary
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Diabetes Care Electronic Pages
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024384/ https://www.ncbi.nlm.nih.gov/pubmed/21270175 http://dx.doi.org/10.2337/dc10-2235

Ejemplares similares

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 2
por: Bloomgarden, Zachary T.
Publicado: (2011)

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 3
por: Bloomgarden, Zachary T.
Publicado: (2011)

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 4
por: Bloomgarden, Zachary T.
Publicado: (2011)

World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 1
por: Bloomgarden, Zachary T.
Publicado: (2011)

Insulin Concerns and Promises
por: Bloomgarden, Zachary T.
Publicado: (2011)

Diabetes and Cardiovascular Disease
por: Bloomgarden, Zachary T.
Publicado: (2011)

Diabetes Treatment and Cardiovascular Safety
por: Bloomgarden, Zachary T.
Publicado: (2011)

American Diabetes Association Postgraduate Meetings—2011
por: Bloomgarden, Zachary T.
Publicado: (2011)

Final “Perspectives on the News”: American Association of Clinical Endocrinology and American Diabetes Association 2011
por: Bloomgarden, Zachary T.
Publicado: (2011)

Nonnutritive Sweeteners, Fructose, and Other Aspects of Diet
por: Bloomgarden, Zachary T.
Publicado: (2011)

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
por: Cavelti-Weder, Claudia, et al.
Publicado: (2012)

Liraglutide Treatment in a Patient With HIV and Uncontrolled Insulin-Treated Type 2 Diabetes
por: Diamant, Michaela, et al.
Publicado: (2012)

Association of Type B Insulin Resistance and Type 1 Diabetes Resulting in Ketoacidosis
por: Bourron, Olivier, et al.
Publicado: (2012)

Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
por: Yanai, Hidekatsu, et al.
Publicado: (2011)

Lipoatrophy in a Girl With Type 1 Diabetes: Beneficial Effects of Treatment With a Glucocorticoid Added to an Insulin Analog
por: Swelheim, Hester T., et al.
Publicado: (2012)

A Case of Insulin-Dependent Diabetes Associated With Enteroviral Infections
por: Hamasaki, Hidetaka, et al.
Publicado: (2012)

Insulin Edema in a Patient With Cystic Fibrosis–Related Diabetes
por: O'Neal, Katherine S., et al.
Publicado: (2012)

Comment on: Luijf et al. Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes. Diabetes Care 2010;33:2152–2155
por: Scaramuzza, Andrea E., et al.
Publicado: (2011)

Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594
por: Tobar, Natália, et al.
Publicado: (2012)

Response to Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594
por: Ramos-Zavala, Maria G., et al.
Publicado: (2012)

Response to Comment on: Luijf et al. Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes. Diabetes Care 2010;33:2152–2155
por: Luijf, Yoeri M., et al.
Publicado: (2011)

Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes
por: Cavelti-Weder, Claudia, et al.
Publicado: (2011)

Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554
por: Rayner, Christopher K., et al.
Publicado: (2011)

Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554
por: Knop, Filip K.
Publicado: (2011)

Response to Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554
por: Taylor, Roy, et al.
Publicado: (2011)

Response to Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554
por: Taylor, Roy, et al.
Publicado: (2011)

Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837
por: Sonmez, Alper, et al.
Publicado: (2011)

Does Therapy With Anti–TNF-α Improve Glucose Tolerance and Control in Patients With Type 2 Diabetes?
por: Gupta-Ganguli, Malini, et al.
Publicado: (2011)

Type 2 Diabetes and Impaired Glucose Tolerance in Two Young Adults Infected With HIV Early in Life
por: Dimock, David, et al.
Publicado: (2011)

Response to Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
por: Ekinci, Elif I., et al.
Publicado: (2011)

Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837
por: Jones, T. Hugh, et al.
Publicado: (2011)

Decreased High Molecular Weight Adiponectin in Sera Is Associated With White Matter Lesions in Japanese Men With Type 2 Diabetes
por: Masaki, Takayuki, et al.
Publicado: (2011)

General Practitioners’ Barriers to Physical Activity Negatively Influence Type 2 Diabetic Patients’ Involvement in Regular Physical Activity
por: Duclos, Martine, et al.
Publicado: (2011)

Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial
por: Choi, Hyung Jin, et al.
Publicado: (2011)

Advanced Glycation End Products in Children With Type 1 Diabetes: Family Matters?
por: Barat, Pascal, et al.
Publicado: (2012)

Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276
por: Rossen, Niklas B., et al.
Publicado: (2011)

Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
por: Natarajan, Sabareesh, et al.
Publicado: (2012)

Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229
por: Khalangot, Mykola D.
Publicado: (2011)

Response to Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276
por: Hermida, Ramón C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eibvfh3ha16sdtpi64gqkjlcue